Controlled release of vancomycin from 3D porous graphene-based composites for dual-purpose treatment of infected bone defects
Open Access
- 12 January 2017
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 7 (5) , 2753-2765
Abstract
Infected bone defects (IBD) are a challenging problem in orthopedic practice. Biomaterials have attracted attention as a novel approach to overcome this challenge instead of using conventional strategies. Graphene, a two-dimensional carbon allotrope, has been shown to possess multiple advantages, such as osteogenesis-promoting activity, a large surface area for drug delivery, and antibacterial activities. However, these attractive merits have not been entirely explored or introduced for the management of IBD. Herein, a novel approach using a vancomycin-laden, self-assembled, graphene-based material against IBD was developed, and the approach uses a single-stage bone graft instead of multiple procedures. Owing to the π–π bonding with graphene, vancomycin can be promptly delivered in the initial stage, followed by a sustained release, which ensures the rapid elimination of an infection and provides a durable pathogen revival inhibition via the inherent antibacterial activity of graphene. Moreover, the 3D porous structure incorporated with nano-hydroxyapatite (nHA) provided a biomimetic microenvironment favored by cell adhesion and osteogenic differentiation. Further evaluation of this system in an IBD animal model demonstrated prompt control of infection and promotion of bone regeneration. These results revealed the potential of this approach to be an effectual solution for IBD treatment and a new area of graphene application in the future.Keywords
Funding Information
- Science and Technology Commission of Shanghai Municipality (15411950600)
- National Natural Science Foundation of China (312111282, 31271031, 8141101156)
This publication has 57 references indexed in Scilit:
- Unique Antimicrobial Effects of Platelet‐Rich Plasma and Its Efficacy as a Prophylaxis to Prevent Implant‐Associated Spinal InfectionAdvanced Healthcare Materials, 2013
- Controlled release of drug from folate-decorated and graphene mediated drug delivery system: Synthesis, loading efficiency, and drug release responseMaterials Science and Engineering: C, 2011
- Graphene for Controlled and Accelerated Osteogenic Differentiation of Human Mesenchymal Stem CellsACS Nano, 2011
- Antimicrobial tolerance and the significance of persister cells in recalcitrant chronic wound biofilmsWound Repair and Regeneration, 2011
- Simple methods for tuning the pore diameter of mesoporous carbonChemical Communications, 2011
- Novel antibacterial nanofibrous PLLA scaffoldsJournal of Controlled Release, 2010
- Functional Graphene Oxide as a Nanocarrier for Controlled Loading and Targeted Delivery of Mixed Anticancer DrugsSmall, 2010
- Resorbable bioactive ceramic for treatment of bone infectionJournal of Biomedical Materials Research Part A, 2010
- Nano-graphene oxide for cellular imaging and drug deliveryNano Research, 2008
- Nanohydroxyapatite microspheres as delivery system for antibiotics: Release kinetics, antimicrobial activity, and interaction with osteoblastsJournal of Biomedical Materials Research Part A, 2007